Tingting Hu

ORCID: 0000-0002-5323-0702
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Epilepsy research and treatment
  • Antibiotics Pharmacokinetics and Efficacy
  • Pharmacovigilance and Adverse Drug Reactions
  • Effects of Radiation Exposure
  • Pharmacological Effects and Toxicity Studies
  • Neuroscience and Neuropharmacology Research
  • Blood disorders and treatments
  • Acupuncture Treatment Research Studies
  • Dermatological and COVID-19 studies
  • Healthcare and Venom Research
  • COVID-19 Clinical Research Studies

Cangzhou Central Hospital
2025

Sichuan University
2023-2024

West China Hospital of Sichuan University
2023-2024

The "Anchang" Group Prescription (ACZF), based on the traditional Bai Tou Weng Decoction and Si Jun Zi Decoction, has demonstrated clinical efficacy in alleviating symptoms of radiation enteritis (RE). Nevertheless, precise active components their underlying molecular mechanisms ACZF's effect RE require further elucidation. This investigation seeks to delineate explore by which ACZF mitigates RE, utilizing both network pharmacology experimental approaches provide a solid theoretical base for...

10.3389/fphar.2025.1524925 article EN cc-by Frontiers in Pharmacology 2025-04-08

Drug-induced seizures are a common occurrence in clinical practice, with research indicating that around 6% of initial due to drug toxicity. The use antibiotics is one such cause drug-related seizures. Previous systematic review has identified specific pose risk seizures, but comprehensive analysis large patient sample needed determine the associated various drugs.This study aimed evaluate association between and presently accessible.To identify potential signals from US Food Drug...

10.1080/14740338.2023.2234825 article EN Expert Opinion on Drug Safety 2023-07-07

Background: Given that the fight against coronavirus disease 2019 (COVID-19) is not over, we aimed to explore occurrence of agranulocytosis and infectious complications in patients with without COVID-19 following immunoregulatory therapy based on real-world data. Methods: This was a retrospective disproportionality analysis US Food Drug Administration Adverse Event Reporting System (FAERS). All cases reported between first quarter 2004 fourth 2022 about Janus kinase inhibitors (baricitinib,...

10.3389/fphar.2023.1323240 article EN cc-by Frontiers in Pharmacology 2024-01-09
Coming Soon ...